Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) saw a large growth in short interest during the month of July. As of July 31st, there was short interest totaling 159,700 shares, agrowthof368.3% from the July 15th total of 34,100 shares. Approximately0.0% of the shares of the stock are sold short. Based on an average daily volume of 374,400 shares, the short-interest ratio is presently 0.4 days. Based on an average daily volume of 374,400 shares, the short-interest ratio is presently 0.4 days. Approximately0.0% of the shares of the stock are sold short.
Fujifilm Price Performance
Shares of OTCMKTS FUJIY traded up $0.17 during mid-day trading on Friday, reaching $12.18. The company had a trading volume of 75,692 shares, compared to its average volume of 234,009. The company has a current ratio of 1.40, a quick ratio of 0.92 and a debt-to-equity ratio of 0.14. The stock has a market cap of $30.30 billion, a PE ratio of 10.97, a P/E/G ratio of 3.63 and a beta of 0.67. The company has a 50-day moving average price of $10.70 and a two-hundred day moving average price of $10.45. Fujifilm has a 1-year low of $8.69 and a 1-year high of $13.88.
Fujifilm (OTCMKTS:FUJIY - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $0.15 earnings per share for the quarter, hitting analysts' consensus estimates of $0.15. The firm had revenue of $5.08 billion for the quarter, compared to analysts' expectations of $760.41 billion. Fujifilm had a return on equity of 7.73% and a net margin of 7.93%. On average, equities analysts anticipate that Fujifilm will post 0.66 earnings per share for the current year.
Analyst Ratings Changes
Separately, Wall Street Zen lowered shares of Fujifilm from a "buy" rating to a "hold" rating in a research report on Friday, May 23rd.
Check Out Our Latest Stock Analysis on FUJIY
About Fujifilm
(
Get Free Report)
FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fujifilm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fujifilm wasn't on the list.
While Fujifilm currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.